George Abongomera

Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

Nicholas I. Paton, Cissy Kityo, Anne Hoppé et al. · New England Journal of Medicine · 2014 · 205 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial

Veronica Mulenga, Victor Musiime, Adeodata Kekitiinwa et al. · The Lancet Infectious Diseases · 2015 · 48 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts

Francis Bajunirwe, Flora P. Tumwebaze, Denis Akakimpa et al. · BioMed Research International · 2018 · 38 citations · Full text

Public Health, Community Health, Health Policy +17

The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe

Adrienne K. Chan, Deborah Ford, Harriet Namata et al. · BMC Health Services Research · 2014 · 36 citations · Full text

Public Health, Community Health, Infectious Disease Control +17